AI
Abdul Irshad Bashir Pathan
About Abdul Irshad Bashir Pathan
Data last updated:
Abdul Irshad Bashir Pathan is a Director at Alright Hospital Private Limited (since 2022) and Director at Nextsphere Pharma Private Limited (since 2025). The companies operate in Healthcare. The largest current company by reported revenue is Alright Hospital Private Limited at ₹3.04 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Jul 2022 | 2022 | ₹3.04 Cr (FY 2024) | Active | |
| Director | 15 Feb 2025 | 2025 | Active |
Board colleagues of Abdul Irshad Bashir Pathan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sana Irshad Pathan | 09663312 | Alright Hospital Private Limited , Nextsphere Pharma Private Limited | Director |
| Sahil Khan | 10864356 | Nextsphere Pharma Private Limited | Director |
| Shaikh Sohel Shaikh Rafik | 10921599 | Nextsphere Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Abdul Irshad Bashir Pathan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abdul Irshad Bashir Pathan
Abdul Irshad Bashir Pathan currently holds 2 directorships: Alright Hospital Private Limited (Director, since 05 Jul 2022, revenue ₹3.04 Cr (FY 2024)); Nextsphere Pharma Private Limited (Director, since 15 Feb 2025).
Abdul Irshad Bashir Pathan was first appointed on 05 Jul 2022 as Director at Alright Hospital Private Limited. The most recent appointment on record is 15 Feb 2025 at Nextsphere Pharma Private Limited.
The current boards of Abdul Irshad Bashir Pathan's companies include Sana Irshad Pathan (Alright Hospital Private Limited), Sahil Khan (Nextsphere Pharma Private Limited), Shaikh Sohel Shaikh Rafik (Nextsphere Pharma Private Limited).